Midline NK/T-cell lymphoma nasal-type: Treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors

Hematological Oncology

Volumn 24, Issue 1, 2006, Pages 28-32

  Yong, Weiben ^a   Zheng, Wen ^a   Zhu, Jun ^a   Zhang, Yuntao ^a   Wei, Yan ^a   Wang, Xiaopei ^a   Lin, Ningjing ^a   Xie, Yan ^a   Xu, Be ^a   Li, Jiyou ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

L asparaginase; Midline NK T cell lymphoma; Prognosis; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARAGINASE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; GLYCOPROTEIN P; PREDNISONE; VINCRISTINE;

ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; HYPOALBUMINEMIA; LEUKOPENIA; MALE; MIDLINE NATURAL KILLER T CELL LYMPHOMA NASAL TYPE; PRIORITY JOURNAL; PROGNOSIS; RASH; SALVAGE THERAPY; SCHOOL CHILD; SURVIVAL RATE; T CELL LYMPHOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NOSE NEOPLASMS; PREDNISOLONE; PROGNOSIS; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 33645210475     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.765     Document Type: Article

References (22)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84: 1361-1392.
2. Jaffe ES: Introduction to the WHO classification. Am J Surg Pathol 1997; 21: 114-121.
3. Jaffe ES, Chan JKC, Su IJ, et al. Report of the Workshop on Nasal and related extranodal angiocentric T/Nature Killer cell lymphomas definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996; 20(1): 103-111.
4. Tao Q, Ho FCS, Loke SL, et al. Epstein-Barr virus is localized in the tumor cells of nasal lymphoma of NK, T or B cell type. Int J Cancer 1995; 60: 315-320.
5. Shibuya. A. Development and functions of natural killer cells. Int J Hematol 2003; 78: 1-6.
6. Jaffe ES, Krenacs L, Kumar S, et al. Extranodal peripheral T-cell NK-cell neoplasms. Am J Clin Pathol 1999; 3(Supp 1): S46-S55.
7. Liang R, Todd D, Chan TK, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncology 1995; 13: 666-670.
8. Kim BS, Kim TY, Kim CW, et al. Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy. Acta Oncolgia 2003; 42(7): 779-783.
9. Li CC, Tien HF, Tang JL, et al. Treatment outcomes and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 2004; 100(2): 366-375.
10. Cheung MMC, Chan JKC, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998; 16: 70-77.
11. Cheung MM, Chan JK, Lau WH, et al. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002; 54(1): 182-190.
12. Kim WS, Song SY, Ahn YC, et al. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol 2001; 12(3): 349-352.
13. Kim GE, Lee SW, Chang SK, et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiotherapy and Oncology 2001; 61: 261-269.
14. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
15. Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 1992; 80: 2735-2739.
16. Yamaguchi M, Kita, K, Miwa H, et al. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer 1995; 76: 2351-2356.
17. Yong W, Zheng W, Zhang J, et al. The efficacy of L-asparaginase in the treatment of refractory midline peripheral T-cell lymphoma. Chin J Hematol 2000; 21(11): 577-579.
18. Yong W, Zheng W, Zhu J, et al. L-asparaginase-based regimen in the treatment of refractory midline T/NK-cell lymphoma. Int J Hematol 2003; 78: 163-167.
19. Nagafuji K, Fujisaki t, Arima F, et al. L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation. Int J Hematol 2001; 74: 447-450.
20. Codegoni AM, Biondi A, Conter V, et al. Human monocytic leukemia expresses low levels asparagine synthase and is potentially sensitive to L-asparaginase. Leukemia 1995; 9(2): 360-361.
21. Sherf U, Ross DT, Waltthom M, et al. A gene expression data base for the molecular pharmacology of cancer. Nat genet 2000; 24(3): 236-244.
22. Kitoh T, Suzuki T, Nagafuji K, et al. Identification of L-asparaginase sensitivity nasal natural killer/natural killer-like T-cell lymphoma: usefulness of immunostaining result for asparagine synthetase in lymphoma cells. Ketsueki-Schuyou-Ka 2003; 46: 108-109.